Insulin Pump Market USD 8520.9 Million Size by Top 10 Players at 8.4% of CAGR Forecasts by 2023 | MRFR

The Insulin Pump Market report summarizes rising prevalence of diabetes across the globe likely to drive the demand for insulin pumps in the forthcoming years. High healthcare expenditure and presence of advanced health care setup supporting the insulin pump market in North America. Pune, India, Sept. 07, 2018 (GLOBE NEWSWIRE) — Insulin Pump Market Summary Insulin pump, also known as continuous subcutaneous insulin is a ground-breaking medical device. Data released by World Health Organization (WHO) revealed that the number of diabetic people worldwide has increased from 108 million in 1980…

Read More

Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma

EXTON, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to FCX-013, the Company’s clinical stage candidate for the treatment of moderate to severe localized scleroderma—a chronic, debilitating genetic skin disorder with no FDA approved therapies. “Fast Track designation represents an important milestone in advancing clinical development of FCX-013,” said John Maslowski, President and Chief Executive Officer…

Read More

ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial

QR-110 demonstrated rapid and sustained improvement in vision in the majority of subjects, as measured by visual acuity and mobility course QR-110 was well-tolerated with no serious adverse events A Phase 2/3 pivotal trial is expected to start in the first half of 2019 Management to host a conference call today at 8:15 a.m. ET LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare…

Read More

DEMAND FOR MEDICAL OFFICE SPACE THROUGH 2019 LIKELY TO EXCEED SUPPLY IN SOME U.S. MARKETS

Rise in Creative Use of Nontraditional Properties Expected to Fulfill Future Needs HOUSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) — In a new study on the healthcare real estate sector, Transwestern today reveals that swelling demand for healthcare services may push forecasted demand for medical office space well above supply in several U.S. markets. The report, Medical Office Space Gets Tight, bases its predictions on the anticipated growth in healthcare workers through 2019 and compares average space usage per worker to space that now exists or is currently under construction in…

Read More

HealthLynked Corp. Creates Data Archive with over 15,000 Medical Articles Covering a Wide Range of Medical Topics for Use in its AI Architecture

NAPLES, Fla., Sept. 04, 2018 (GLOBE NEWSWIRE) — HealthLynked Corp. (OTCQB: HLYK) today announced that it has created a unique database of over 15,000 medical publications and research articles that it plans to use for its health analytics Artificial Intelligence “AI” service. Information is the driver of all medical decisions and having a robust library of medical information and continually updating this library ensures physicians and members can find the most current and relevant information regarding healthcare decisions. The archive uses Elasticsearch, which can be used to search a wide…

Read More

Fibrocell to Present at 20th Annual Rodman & Renshaw Global Investment Conference

EXTON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that John Maslowski, President and Chief Executive Officer, will present at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H. C. Wainwright & Co., LLC.  Mr. Maslowski’s presentation is scheduled for Wednesday, September 5 at 2:35 p.m. EDT in New York City.  A live webcast of Fibrocell’s presentation will be available under the investor relations section…

Read More

S. Parikh Mars, CEO of Progressive Care Inc., is Featured in a New Audio Interview with SmallCapVoice.com

AUSTIN, Texas, Aug. 29, 2018 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. and Progressive Care Inc. (RXMD), a personalized healthcare services and technology company, announced today that the Company is featured in a new audio interview at SmallCapVoice.com, Inc. The interview featuring RXMD’s CEO, current news and industry trends can be heard at https://smallcapvoice.com/blog/8-28-18-smallcapvoice-interview-with-progressive-care-inc-rxmd/. S. Parikh Mars, CEO of Progressive Care Inc., called into SmallCapVoice.com, Inc. to answer shareholder questions that the company was not able to get to in the recent Q2 earnings call, go over the drivers behind the recently…

Read More

American Premium Water Corp. (HIPH) Starts Process To Retire 6 million Common Shares

Company’s CBD product launch successful; first day sales exceeded internal projections PLAYA VISTA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) — American Premium Water Corporation (OTC Pink: HIPH) (the “Company”) announces that it has initially identified 6 Million common shares, and has begun the process to have the first retirement of shares returned to treasury. The Company will advise when this process is complete. Additionally, the first day of sales from the Company’s launch of its LALPINA Hydro CBD product surpassed internal projections. Ryan Fishoff, CEO American Premium Water Corporation commented:…

Read More

Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference

WARMINSTER, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia, Arbutus’ Chief Scientific Officer, will participate in the Hepatitis B Functional Cure Panel at the B. Riley FBR Healthcare Conference on Tuesday, September 4, 2018 at 9:50 am – 10:50 am ET in New York. About ArbutusArbutus Biopharma Corporation is a publicly-traded (Nasdaq: ABUS) biopharmaceutical company dedicated to discovering, developing, and commercializing a cure for patients suffering from chronic Hepatitis B infection….

Read More

Dr. William Williams, BriaCell’s President & CEO, is Featured in an Exclusive New Audio Interview at SmallCapVoice.com

AUSTIN, Texas, Aug. 28, 2018 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. and BriaCell Therapeutics Corp. (“BriaCell”) (BCT.V) (BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced today that the Company’s President & CEO, Dr. William Williams, is featured in a new audio interview at SmallCapVoice.com, Inc. The new Bricell interview can be heard at  https://smallcapvoice.com/blog/8-27-18-smallcapvoice-interview-with-briacell-therapeutics-corp-bctxf/.    Dr. Williams, BriaCell’s President & CEO, called in to SmallcapVoice.com to go over the highlights for the Company’s achievements in the summer of 2018 and the expected newsflow from BriaCell in…

Read More